Here, Tony Hitchcock, technical director at Cobra Biologics and Joanne Anderson, business development director at Symbiosis, whose respective companies were recently awarded a 16-month collaborative grant of £1.9 million from Innovate UK, discuss the challenges associated with manufacturing for gene therapies.
Genes
They are cited by many as a ‘medical revolution’. Emerging gene and cell therapies to treat everything from cancer to haemophilia and blindness are being hailed as huge successes.